← Alle mensen

MM

Michael Millward

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
The New England journal of medicine · 22 januari 2026
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic...
The Lancet. Oncology · 2025-05
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024-11
Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars herbeoordeling
European journal of cancer (Oxford, England : 1990) · 2022-09
Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars
The Lancet. Oncology · 2020-11
Langetermijnuitkomsten van dabrafenib monotherapie bij BRAF-gemuteerd melanoom
European journal of cancer (Oxford, England : 1990) · 2020-01